Delivery Order SPE2DB22D3004-SPE2DB25FQ69M
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 29, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This order, valued at $13,846.97 with a firm fixed price structure, represents a non-competitive, non-set-aside procurement issued under a delivery order contract type and is scheduled for completion by August 18, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 for Vyndamax 61 mg capsule unit dose 30-count packages on August 25, 2025. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packaging (30-count) on August 8, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packaging) under a firm fixed-price contract. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (unit dose, 30-count packaging) on August 27, 2025, with a completion date of September 18, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. The contract utilizes firm fixed pricing with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packaging) under a firm fixed price contract. This non-set-aside competitive award was issued on August 14, 2025, with an ultimate completion date of September 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract, issued under firm fixed pricing with no set-aside designation, is scheduled for completion by September 24, 2025, and represents a competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ69MDelivery Order
The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) on September 11, 2025, with an ultimate completion date of October 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary distribution hub for federal pharmaceutical procurement. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen's portfolio demonstrates extensive experience supplying specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 9/11/25 |